Publication | Closed Access
Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis
50
Citations
27
References
2020
Year
Anti-Mi-2β antibodies were associated with a subgroup of DM with a low frequency of ILD and malignancy, good treatment response, and favourable outcome. Moreover, anti-Mi-2β levels correlated with disease activity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1